Lataa...
Prediction and failure of anti-angiogenesis escape
Many clinical trials have demonstrated the benefit of anti-angiogenesis therapy in the treatment of gynecologic cancer. However, these benefits have often been in terms of progression-free rather than overall survival and in some cases, the magnitude of benefit demonstrated in the pivotal phase 3 tr...
Tallennettuna:
| Julkaisussa: | Gynecol Oncol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4808422/ https://ncbi.nlm.nih.gov/pubmed/26748214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2015.12.033 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|